PRQR

#3265
ProQR Therapeutics N.V. - Ordinary Shares
1.5 8 USD
0.00%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.58
1.58
Range Annuel
1.34
3.10
Changement quotidien
0.00%
Changement Mensuel
+1.94%
Evolution sur 6 mois
-32.77%
Changement Annuel
-9.20%
Clôture Précédente
1.5 8
Open
1.5 8
Low
1.5 8
High
1.5 8
Volume
21
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

ProQR Therapeutics N.V. - Ordinary Shares

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.

Nouvelles